Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Bioterror Defense
Forbes.com ^ | 08.13.04, 6:00 AM ET | Forbes staff

Posted on 08/14/2004 12:58:15 AM PDT by Che Chihuahua

Bioterror Defense - Forbes staff, 08.13.04, 6:00 AM ET

NEW YORK - Pharmathene is one of a smattering of small and undercapitalized biotechnology outfits trying to develop either vaccines or antidotes for anthrax, which remains, in the opinion of a lot of experts, the most likely weapon to be used against the U.S. in a bioterror attack.

The threat of biological attack is considered so serious that President George W. Bush in late July signed Project Bioshield, creating a $5.6 billion fund to stockpile treatments for smallpox, botulism and anthrax over ten years, without the need for approval from the U.S. Food & Drug Administration. This fall, Washington will start to free up hundreds of millions of dollars to stockpile anthrax antidotes and $1.4 billion to buy vaccine doses.

The Congressional Budget Office figures the bill could come to $8 billion over ten years. The National Institutes of Health will spend another $1.6 billion this year, up from $291 million in 2002, on bio-defense work.

A mason jar of anthrax sprayed over an urban area could infect 400,000 urban residents and possibly kill half of them in less than two weeks. Such a dispersal would be hard to pull off, but certainly not impossible. A 9/11 Commission staff report concluded in June that al Qaeda "was making advances in its ability to produce anthrax prior to September 11" and cited former CIA director George Tenet as warning that an anthrax attack is "one of the most immediate threats the U.S. is likely to face."

Anthrax is relatively easy to mass-produce. The naturally occurring bacterium, which infests soil and is contracted by grass grazers like cattle or sheep, can be extracted from the blood of an infected animal and grown in petri dishes. An attack might not be detected until people started getting very ill.

Catching the Bad Bug Robert Lenzner & Nathan Vardi http://www.forbes.com/business/free_forbes/2004/0816/070.html


TOPICS: Anthrax Scare; Business/Economy; War on Terror
KEYWORDS: anthrax; bioterrorism; botulism; smallpox
This e-article discusses the new business of bioterror defense. For those who play the stock market, it may provide leads to possible investment opportunities in a growth industry. It also links to a more detailed article on this industry. Too bad there's no defense against the biohazard created by Michael Moore.
1 posted on 08/14/2004 12:58:15 AM PDT by Che Chihuahua
[ Post Reply | Private Reply | View Replies]

To: Che Chihuahua
This article has been posted to DoctorZin’s New News Blog!


2 posted on 08/14/2004 10:25:30 AM PDT by DoctorZIn (Until they are Free, "We shall all be Iranians!")
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson